Brief: Tempest Therapeutics - Justin Trojanowski To Resign As Principal Financial Officer And Principal Accounting Officer Effective Sept 1 - SEC Filing
24/08/2026 21:48
BRIEF-Tempest Therapeutics - Justin Trojanowski To Resign As Principal Financial Officer And Principal Accounting Officer Effective Sept 1 - SEC Filing Aug 24 (Reuters) - Tempest Therapeutics Inc TPST.O:
TEMPEST THERAPEUTICS - JUSTIN TROJANOWSKI TO RESIGN AS PRINCIPAL FINANCIAL OFFICER AND PRINCIPAL ACCOUNTING OFFICER EFFECTIVE SEPT 1 - SEC FILING
TEMPEST THERAPEUTICS - APPOINTS NICHOLAS ROSSETTOS AS CFO, PRINCIPAL FINANCIAL AND ACCOUNTING OFFICER EFFECTIVE SEPT 1, 2026 - SEC FILING
Source text: []
Further company coverage: TPST.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Tempest Therapeutics
See all newsBrief: Tempest Therapeutics - Justin Trojanowski To Resign As Principal Financial Officer And Principal Accounting Officer Effective Sept 1 - SEC Filing
Tempest Therapeutics Inc reports results for the quarter ended June 30 - Earnings Summary
Brief: Tempest Therapeutics - Enters $50 Million Common Stock Purchase Agreement With Lincoln Park
Tempest Therapeutics Inc expected to post a loss of 30 cents a share - Earnings Preview
Brief: Tempest Announces Development Collaboration With Senlang Biotechnology For TPST-4003, A CD7-Targeted Next-Generation In Vivo CAR-T